A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

The Bellmunt Risk Score can provide prognostic information on survival among patients with metastatic castration-resistant prostate cancer, new data suggest.

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Ricky Gervais' longtime partner Jane Fallon shared that she had been diagnosed with breast cancer earlier this year, but was ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer treatment and diagnosis ...

A new law is taking effect in Alabama next year that will make prostate cancer screenings more affordable.

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

Stratford Town FC chairman Jed McCrory is calling on men to get checked for prostate cancer to avoid putting their family ...

A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.